Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat

European Journal of Pharmaceutical Sciences

Volumn 32, Issue 4-5, 2007, Pages 247-253

  Song, Min ^a,b   Hang, Tai Jun ^a   Zhang, Zhengxing ^a   Chen, Hong Yuan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Cryptotanshinone; Herb drug interaction; Pharmacokinetics; Salvia miltiorrhiza Bge.; Tanshinone IIA

Indexed keywords

ALCOHOL; CRYPTOTANSHINONE; DITERPENOID; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE; TANSHINONE IIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TRANSFORMATION; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SALVIA MILTIORRHIZA;

ANIMALS; CHROMATOGRAPHY, LIQUID; DITERPENES; DRUGS, CHINESE HERBAL; FEMALE; MALE; MOLECULAR STRUCTURE; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; TANDEM MASS SPECTROMETRY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 35748982105     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2007.07.007     Document Type: Article

References (25)

1. A on DNA damage by lipid peroxidation in liver cells. Free Radic. Biol. Med. 20 (1996) 801-806
2. Cheng T.O. Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease. Int. J. Cardiol. 113 (2006) 437-438
3. CPC. Pharmacopoeia of People's Republic of China 2005 (2005), Chemical Industry Press, Benjing pp. 52-53
4. Guan S., Bi H.C., Chen X., and Huang M. Transport mechanism of cryptotanshinone across Cao-2 monolayer model. Chin. J. Clin. Pharmacol. 21 (2005) 268-271
5. A in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). J. Pharm. Biomed. Anal. 40 (2006) 382-388
6. Hu P., Luo G.A., Zhao Z.Z., and Jiang Z.H. Quality assessment of Radix Salviae Miltiorrhizae. Chem. Pharm. Bull. 53 (2005) 481-486
7. Jang S., Kim H.J., Kim Y.J., Jeong S., and You Y.O. Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur. J. Pharmacol. 542 (2006) 1-7
8. Ji X.Y., Tan B.K.H., and Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21 (2000) 1089-1094
9. Jiang S.H., Kang L.J., Ye J., Yao S.K., and Liu W.N. Studies on pharmacokinetics of gentiopicrin in longdan and its compound preparation in rats. Chin. Pharm. J. 40 (2003) 212-215
10. Lam F.Y., Ng S.C.W., Cheung J.H.Y., and Yeung J.H.K. Mechanisms of the vasorelaxant effect of Danshen (Salvia miltiorrhiza) in rat knee joints. J. Ethnopharmacol. 104 (2006) 334-336
11. Lay I.S., Chin J.H., Shiao M.S., Lui W.Y., and Wu C.W. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med. 69 (2003) 26-32
12. A and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionization-mass spectrometry. J. Chromatogr. B 826 (2005) 26-30
13. Li P., Wang G.J., Li J., Hao H.P., and Zheng C.N. Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1104 (2006) 336-369
14. Lu T., Song J., Huang F., Deng Y.X., and Xie L. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix Scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. J. Ethnopharmacol. 110 (2007) 412-418
15. Mathews J.M., Etheridge A.S., Valentine J.L., Black S.R., Coleman D.P., Patel P., So J., and Burka L.T. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. Drug. Metab. Dispos. 33 (2005) 1555-1563
16. Ren Y.H., Peter J.H., Robert C.H., and Melanie-Jayne R.H. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorrhiza. Planta Med. 70 (2004) 201-204
17. Ryu S.Y., Lee C.O., and Choi S.U. In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza. Planta Med. 63 (1997) 339-342
18. Song M., Hang T.J., Zhang Z.H.X., Du R., and Chen J. Determination of cryptotanshinone and its metabolite in rat plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 827 (2005) 205-209
19. Song M., Hang T.J., and Zhang Z.H.X. Studies on the fingerprints of the liposoluble components of Salvia miltiorrhiza Bge. by HPLC using fingerprint reference material. Chin. J. Pharm. Anal. 27 (2007) 8-12
20. Wang G.J., Liu X.D., and Liu X.Q. Pharmacokinetics (2005), Chemical Industry Press, Beijing p. 102
21. A against human breast cancer. Int. J. Cancer 116 (2005) 799-807
22. Xue M., Cui Y., Zhang B., Shi Y.B., Zhou Z.T., Luo Y.J., Xia W.J., Zhao R.C., and Wang H.Q. The metabolism of cryptotanshinone in pigs and in vitro. Chin. J. Vet. Sci. 19 (1999) 49-51
23. A in rat small intestine. West. Chin. J. Pharm. Sci. 17 (2002) 246-248
24. Zhang H.Y., Hu Z.D., Yang G.L., and Sun H.W. Determination of β-(3,4-dihydroxyphenyl) lactic acid, protocatechuic acid and protocatechuic aldehyde in Radix Salviae Miltiorrhizae by capillary electrophoresis. Chromatographia 49 (1999) 219-222
25. Zhao B.L., Jiang W., Zhao Y., Hou J.W., and Xin W.J. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. Biol. Int. 38 (1996) 1171-1182